A detailed history of Sphera Funds Management Ltd. transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 118,345 shares of PTCT stock, worth $5.02 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares
118,345
Previous 94,318 25.47%
Holding current value
$5.02 Million
Previous $2.88 Million 52.22%
% of portfolio
0.81%
Previous 0.42%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$30.39 - $37.66 $730,180 - $904,856
24,027 Added 25.47%
118,345 $4.39 Million
Q2 2024

Aug 14, 2024

BUY
$24.69 - $40.12 $2.33 Million - $3.78 Million
94,318 New
94,318 $2.88 Million
Q4 2023

Feb 14, 2024

SELL
$18.07 - $29.37 $1.48 Million - $2.41 Million
-81,934 Reduced 37.51%
136,525 $3.76 Million
Q3 2023

Nov 14, 2023

BUY
$22.41 - $41.99 $2.65 Million - $4.97 Million
118,359 Added 118.24%
218,459 $4.9 Million
Q2 2023

Aug 14, 2023

SELL
$40.4 - $59.1 $2.38 Million - $3.49 Million
-59,000 Reduced 37.08%
100,100 $4.07 Million
Q1 2023

May 15, 2023

BUY
$38.16 - $48.86 $6.07 Million - $7.77 Million
159,100 New
159,100 $7.71 Million
Q1 2020

May 14, 2020

SELL
$32.37 - $59.36 $6.95 Million - $12.7 Million
-214,736 Closed
0 $0
Q4 2019

Feb 13, 2020

SELL
$32.22 - $50.07 $3.07 Million - $4.77 Million
-95,264 Reduced 30.73%
214,736 $10.3 Million
Q3 2019

Nov 14, 2019

BUY
$33.82 - $48.17 $3.03 Million - $4.31 Million
89,500 Added 40.59%
310,000 $10.5 Million
Q1 2019

May 15, 2019

SELL
$28.09 - $39.49 $3.51 Million - $4.94 Million
-125,000 Reduced 36.18%
220,500 $8.3 Million
Q4 2018

Feb 14, 2019

BUY
$29.83 - $46.51 $4.04 Million - $6.3 Million
135,500 Added 64.52%
345,500 $11.9 Million
Q3 2018

Nov 14, 2018

BUY
$33.9 - $47.77 $7.12 Million - $10 Million
210,000 New
210,000 $9.87 Million

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.03B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Sphera Funds Management Ltd. Portfolio

Follow Sphera Funds Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.